A de novo missense mutation in synaptotagmin-1 associated with neurodevelopmental disorder desynchronizes neurotransmitter release

van Boven, Maaike A.; Mestroni, Marta; Zwijnenburg, Petra J. G.; Verhage, Matthijs; Cornelisse, L. Niels

doi:10.1038/s41380-024-02444-5

Download PDF

Article
Open access
Published: 06 February 2024

A de novo missense mutation in synaptotagmin-1 associated with neurodevelopmental disorder desynchronizes neurotransmitter release

Molecular Psychiatry (2024)Cite this article

872 Accesses
2 Altmetric
Metrics details

Subjects

Abstract

Synaptotagmin-1 (Syt1) is a presynaptic calcium sensor with two calcium binding domains, C2A and C2B, that triggers action potential-induced synchronous neurotransmitter release, while suppressing asynchronous and spontaneous release. We identified a de novo missense mutation (P401L) in the C2B domain in a patient with developmental delay and autistic symptoms. Expressing the orthologous mouse mutant (P400L) in cultured Syt1 null mutant neurons revealed a reduction in dendrite outgrowth with a proportional reduction in synapses. This was not observed in single Syt1^PL-rescued neurons that received normal synaptic input when cultured in a control network. Patch-clamp recordings showed that spontaneous miniature release events per synapse were increased more than 500% in Syt1^PL-rescued neurons, even beyond the increased rates in Syt1 KO neurons. Furthermore, action potential-induced asynchronous release was increased more than 100%, while synchronous release was unaffected. A similar shift to more asynchronous release was observed during train stimulations. These cellular phenotypes were also observed when Syt1^PL was overexpressed in wild type neurons. Our findings show that Syt1^PL desynchronizes neurotransmission by increasing the readily releasable pool for asynchronous release and reducing the suppression of spontaneous and asynchronous release. Neurons respond to this by shortening their dendrites, possibly to counteract the increased synaptic input. Syt1^PL acts in a dominant-negative manner supporting a causative role for the mutation in the heterozygous patient. We propose that the substitution of a rigid proline to a more flexible leucine at the bottom of the C2B domain impairs clamping of release by interfering with Syt1’s primary interface with the SNARE complex. This is a novel cellular phenotype, distinct from what was previously found for other SYT1 disease variants, and points to a role for spontaneous and asynchronous release in SYT1-associated neurodevelopmental disorder.

Presynaptic dysfunction in CASK-related neurodevelopmental disorders

Article Open access 14 September 2020

Aberrant expression of S-SCAM causes the loss of GABAergic synapses in hippocampal neurons

Article Open access 09 January 2020

Structural deficits in key domains of Shank2 lead to alterations in postsynaptic nanoclusters and to a neurodevelopmental disorder in humans

Article Open access 30 November 2022

Introduction

Information processing in the brain depends on fast neurotransmission in synapses synchronized with presynaptic action potential (AP) activity. When an AP invades the presynaptic terminal, the rapid rise in calcium activates a set of specialized proteins which catalyze the synchronous fusion of neurotransmitter-filled synaptic vesicles [1]. This core fusion machinery comprises three soluble N-ethylmaleimide sensitive factor attachment protein receptors (SNAREs), that together provide the energy for fusion. It also includes key regulatory factors involved in the assembly and activation of the SNARE complex [2]. Mutations in genes encoding components of the core fusion machinery are increasingly found to underlie neurodevelopmental symptoms in patients [3,4,5] and define a new class of neurodevelopmental disorders referred to as SNAREopathies [6].

In recent years, several patients with neurodevelopmental symptoms of various severity have been described with de novo heterozygous missense mutations in the gene SYT1 [7, 8]. SYT1 encodes the calcium sensor Synaptotagmin-1 (Syt1) and belongs to the synaptotagmin family, a group of membrane associating proteins that contain two calcium binding C2 domains [9]. Among the 17 synaptotagmins, Syt1 is the predominant paralog for fast release in the forebrain [10], involved in vesicle docking, priming, fusion and endocytosis [9, 11,12,13,14,15]. Syt1’s primary role is to time-lock neurotransmitter release with millisecond precision to presynaptic APs, and to prevent asynchronous and spontaneous release between APs [16,17,18,19]. Before Ca²⁺-influx, the C2B domain binds the SNARE complex through the so-called primary interface [20, 21]. This prefusion Syt1-SNARE complex is thought to hinder membrane fusion, and to keep the release machinery in a state ready for fast release. During AP-induced Ca²⁺-influx, calcium binding to the Ca²⁺-binding loops of C2B induces their insertion into the membrane (disturbing the lipid bilayer), releasing the Syt1-SNARE interaction and enabling cooperation between Syt1 and the SNAREs in membrane fusion [20, 21]. Most of the pathogenic mutations in individuals with NDDs cluster at the Ca²⁺-binding sites in the C2B domain [7, 22], although mutations in the C2A domain were also reported [8]. These C2B mutants delayed release kinetics when overexpressed in wild type neurons, and failed to support evoked release when expressed in a Syt1 null background [7, 22, 23]. This has led to the idea that disruption of the Ca²⁺-dependent fusion role of Syt1 is the main molecular cause of Syt1 associated developmental disorders [23].

In this paper we describe an individual presenting with developmental delay and carrying a de novo heterozygous mutation c.1202 C > T, resulting in missense variant Pro401Leu. This substitution does not locate to a calcium-binding site, but flanks the C2B bottom face involved in membrane [12, 24] and SNARE [20, 25] binding. We show that the ability of Syt1 to suppress spontaneous and asynchronous release is impaired by this mutation, while its release triggering function is not affected. This novel phenotype is distinct from cellular phenotypes found for other SYT1 disease mutations and points towards a role for release synchronization in normal brain development.

Results

A novel de novo missense mutation in SYT1 in a patient with development delay and autistic symptoms

A 5.5 years old boy visited our multidisciplinary outpatient clinic because of unexplained tall stature, autistic features, and a mild developmental delay. He was born after an uneventful pregnancy at 41 weeks gestational age and his birth weight was 5 kg. He is the second child of non-consanguineous parents with unremarkable family history. His father was also tall as a child and his current height is 196 cm (+1.7 SD). Patient’s target height is +0.84 SD. Upon physical examination the boy had a height at +2.9 SD with normal weight and head circumference. He displayed mild hypermobility of the joints. No dysmorphic features were observed, except for widely spaced teeth and persistent fetal finger pads. He had one hyperpigmentation on his arm. At the age of 2 years old, his parents noted staring episodes. An EEG was performed but no abnormalities were found. His motor development was mildly delayed, and he started walking at the age of 22 months. His speech development was limited to a few words at the age of 36 months. At his first visit he spoke full sentences. He attended regular school, but experienced learning and behavioral problems (impaired concentration, limited interaction with his peers) and currently attends special needs education. At the age of 5 years, a pervasive developmental disorder not otherwise specified was diagnosed. His total intelligent quotient (IQ) was estimated 64–81 based on intelligence tests (the Dutch Wechsler Preschool and Primary Scale of Intelligence-Third edition (WPPSI-III-NL)). In particular, sensory-processing and information-processing difficulties were identified and the child psychiatrist confirmed a neurobiological developmental disorder. At the age of 10 years he is able to walk, run and cycle. On the Vineland Adaptive Behavior Scales-3 his adaptive behavior on communication and socialization domains was measured as moderate-to-low skill level and on the daily living skills domain his adaptive skills were on an adequate-to-high level. Brain imaging as not been performed.

Compared to other cases with missense mutations in SYT1 [7] or a deletion of SYT1 [26] the patient described here appears to be mildly affected. The majority of these previously described cases, aged 3–21 years, had absent speech, delayed motor development, movement disorders such as dystonia or stereotypies and infant hypotonia. Their growth was normal. The phenotype of the patient described here shows overlap with these cases (delayed motor and speech development, joint hypermobility, neurobiological developmental disorder), but is remarkably milder.

The patient showed normal endocrine functions. Genetic testing revealed a normal male karyotype (46,XY), a normal repeat length of the (CGG)n repeat of the FMR1-gene, and SNP array analysis (Affymetrix CytoScan® HD) showed a normal male array pattern. Whole exome sequencing of DNA isolated from blood samples of the patient and his parents (performed with an Illumina HiSeq 4000 instrument) demonstrated a heterozygous missense variant in SYT1 (NM_005639.2(SYT1):c.1202 C > T p.(Pro401Leu) (Chr12(GRCh37):g.79842837 C > T)). This variant was not present in his parents.

The Pro401 residue is evolutionary conserved among various vertebrate and invertebrate orthologs, as well as in the human paralog Synaptotagmin-2 (Fig. 1A). No variation was found at this position in more than 76 000 genomes from healthy individuals of diverse ancestries in the gnomAD database (v3.1.2; https://gnomad.broadinstitute.org), indicating that Pro401Leu is not a common variant [27, 28]. Pro401 is located at the bottom of the C2B domain (Fig. 1B), opposite to the top Ca²⁺ binding loops, where previously characterized [7, 22, 23] mutations are located. The mutated proline is positioned next to two arginine residues (R399, R400) that directly interact with SNAP25 to form the primary Syt1-SNARE interface (inset Fig. 1B) [20, 21, 29] important for evoked synchronous release and suppression of spontaneous release [21, 29,30,31]. Altogether, this suggests that Pro401 could be an important residue for the function of Syt1, and that substitution with a Leucine at this location could have a pathogenic effect.

**Fig. 1: De novo missense mutation Syt1 Pro401Leu reduces dendrite length and synapse number.**

Syt1^PL inhibits dendritic maturation

To investigate the effect of the patient Syt1 mutation Pro401Leu on neuronal development and synaptic transmission, we used lentiviral expression vectors containing an F2A-linked GFP (Fig. S1B) to express murine Syt1 carrying the homologous mutation Pro400Leu (Fig. 1A) (Syt1^P400L; hereafter referred to as Syt1^PL) or wild type Syt1 (Syt1^WT) in cultured autaptic hippocampal neurons from Syt1 knockout mice [32, 33]. Autaptic neurons or “autapses” are single neurons cultured on micro-islands that innervate their own dendritic tree (Fig. 1C), allowing the assessment of morphological and synaptic parameters of individual neurons in a standardized manner [34, 35]. Immunostaining revealed that expression of Syt1 and GFP were similar between Syt1^WT and Syt1^PL-rescued neurons, and at the same ratio (Fig. S1A, C). Furthermore, Syt1 showed a high degree of colocalization with the presynaptic marker VGLUT1 (Fig. 1D, Fig. S1D), which was the same for Syt1^PL and Syt1^WT (Fig. S1D). Together, this indicates that that protein stability and synaptic targeting are unaffected by the PL mutation.

To assess the impact of the PL mutation on neuronal morphology, dendrites and synapses were visualized using MAP2 staining and VGLUT1/Syt1 staining, respectively (Fig. 1D) and analyzed with the semi-automated image analysis tool SynD [36]. Expression of Syt1^PL decreased total dendrite length per neuron by 30% (Fig. 1E), with a concomitant reduction in the number of VGLUT1⁺/Syt1⁺ synaptic puncta as compared to Syt1^WT-rescued neurons (Fig. 1F), but had no effect on synapse density (Fig. 1G). The size of VGLUT1⁺/Syt1⁺ synaptic puncta was the same in Syt1^PL- and Syt1^WT-rescued neurons (Fig. 1H). Dendritic branching, as quantified by Sholl analysis, was also reduced (Fig. 1I). These results indicate that Syt1^PL affects dendrite outgrowth or stability, but not synaptogenesis.

Syt1^PL impairs suppression of asynchronous release

Syt1’s main function is to trigger neurotransmitter release in response to a presynaptic AP [37]. To examine the impact of the patient mutation on AP-triggered release, we measured evoked postsynaptic currents (EPSCs) in autaptic hippocampal Syt1 null neurons rescued with either Syt1^PL or Syt1^WT using whole-cell voltage-clamp. The amplitude of EPSCs was considerably reduced in Syt1^PL-rescued neurons as compared to Syt1^WT-rescued neurons (Fig. 2A, B). Paired-pulse stimulations showed that the release probability did not differ between the groups (Fig. S2A, B). Despite a reduced amplitude, the total amount of release, as measured by EPSC charge [38] did not differ (Fig. 2C). This suggested that the time course of release was slower and more prolonged in Syt1^PL-rescued neurons. However, rise times, measured as the time from stimulation onset to the peak of the EPSC, were the same for Syt1^PL and Syt1^WT (Fig. 2D). In order to quantify the EPSC decay time courses we fitted the decay phase with bi-exponential fits (Fig. 2A). While the decay time constants for the fast and slow components (τ_fast and τ_slow) were indistinguishable (Fig. 2F), the relative amplitude of the slow component was considerably larger in EPSCs from Syt1^PL neurons compared to Syt1^WT (Fig. 2E; Fig. S2C, D). We calculated the amount of synchronous and asynchronous release during a single EPSC by: (1) adding the current integrals of the rise phase and the fast component of decay to obtain the total amount of synchronous release (Fig. S2E), and (2) integrating the EPSC’s slow decay component to obtain asynchronous release (Fig. S2F). Compared to Syt1^WT, Syt1^PL-rescued neurons displayed a two-fold increase in the contribution of asynchronous release to the total amount of release per EPSC (Fig. 2G). Taken together, these data show that the PL mutation increases an asynchronous component in evoked release that is almost absent in Syt1^WT -rescued neurons.

**Fig. 2: Syt1^PL desynchronizes neurotransmission.**

Syt1 also synchronizes neurotransmission by suppressing asynchronous release during prolonged stimulation [19]. To probe this function, we assessed synchronous and asynchronous release during 20 Hz stimulus trains (Fig. 2H). Rundown of synchronous EPSCs was unaffected in Syt1^PL neurons (Fig. 2I). In line with the results for single EPSCs, Syt1^PL and Sy1^WT-rescued neurons transferred the same amount of charge during 20 Hz trains, but in Syt1^PL, asynchronous release accounted for a larger fraction of the total release during the train (Fig. 2J). In addition, asynchronous release directly following the train (‘tail current’) was increased in Syt1^PL neurons, as evidenced by a slower decay to baseline (Fig. 2H, K). These data show that the PL substitution also promotes asynchronous release during, and directly after, prolonged stimulation.

We employed 40 Hz stimulus trains (Fig. 2L) to estimate the total pool of readily releasable vesicles (RRP) and the vesicle recruitment rate [39]. The total charge transferred during 40 Hz stimulation did not differ between Syt1^WT and Syt1^PL-rescued neurons (Fig. S2G). Likewise, both RRP size and recruitment rate were similar in neurons expressing Syt1^PL and Syt1^WT (Fig. 2M). To corroborate our findings, we used hypertonic sucrose (500 mM) application as an independent approach to assess RRP size [35, 40] and again found no difference in RRP size (Fig. 2N, O), despite the reduced number of synapses in Syt1^PL-expressing neurons (Fig. 1E). This suggests that Syt1^PL-rescued neurons have more primed vesicles per synapse.

Syt1^PL has a dominant-negative effect on dendrite length and suppression of asynchronous release

To investigate whether the Syt1^PL variant affects neuronal morphology and synaptic function in the presence of WT Syt1, we overexpressed Syt1^PL or Syt1^WT in wild type (WT) neurons. All morphological and electrophysiological phenotypes found on the Syt1 KO background were confirmed, although with somewhat smaller effect sizes (see Table S1). Immunostaining for MAP2 and VGLUT1 (Fig. 3A) revealed that compared to overexpression of Syt1^WT, overexpression of Syt1^PL reduced dendrite length by 17% (Fig. 3B), with a proportional reduction in the number of synapses (Fig. 3C). Dendritic branching was likewise reduced (Fig. 3F), while synapse size and density were unaffected (Fig. 3D, E). EPSC amplitude, charge and time-to-peak did not differ (Fig. 4A–D). Again, time constants for the fast and slow components of the EPSC decay phase were not different (Fig. 4F), but the slow component contributed more to the total amplitude of Syt1^PL EPSCs (Fig. 4E, Fig. S4A, B), which was associated with a 61% increase in the asynchronous fraction of release compared to Syt1^WT (Fig. 4G, Fig. S4C, D). Similarly, we found an increase in the asynchronous fraction of release during 20 Hz trains, and a slower decay of the tail current after stimulation (Fig. 4H–K). Finally, the total charge released during a 40 Hz train, as well as the RRP and recruitment rate estimated from back-extrapolation, did not differ between the two groups (Fig. 4L–N). Altogether, these results indicate a dominant-negative effect of Syt1^PL on dendrite length and suppression of asynchronous release.

**Fig. 3: Syt1^PL reduces dendrite length and synapse number in the presence of endogenous Syt1^WT.**

**Fig. 4: Syt1^PL increases asynchronous release in the presence of endogenous Syt1^WT.**

Syt1^PL has a dominant-negative effect on the suppression of spontaneous miniature release events

Syt1 suppresses spontaneous vesicle fusion, preventing premature release from the RRP [16, 41, 42]. Given that the Syt1^PL failed to effectively suppress asynchronous release, we next examined Syt1^PL’s ability to suppress spontaneous miniature release. Indeed, analysis of miniature EPSC (mEPSC) rates revealed a 4-fold higher rate in Syt1 null neurons rescued with Syt1^PL as compared those rescued with Syt1^WT (Fig. 5A, B). In addition, mEPSC amplitudes were increased in Syt1^PL neurons (Fig. 5B), likely due to spurious summation of independent spontaneous events at these high release rates [43, 44]. To confirm this supposition and exclude the presence of any postsynaptic effect, we repeated the experiment in younger neurons (DIV10) where mEPSC rates are still low, and found that mEPSC amplitudes were unaffected (Fig. S5), arguing against the presence of any postsynaptic effect of Syt1^PL. When measured in mass culture in the presence of TTX (1 μM), a similar increase in mEPSC frequency was observed (Fig. 5C, D), confirming that Syt1^PL impairs the suppression of spontaneous miniature release and that the phenotype is not specific to autaptic cultures. Furthermore, overexpression of Syt1^PL on a WT background yielded a similar 3-fold increase in mEPSC release rates compared to Syt1^WT overexpression (Fig. 5E, F), with no differences in mEPSC amplitude (Fig. 5F). Together, these data suggest that Syt1^PL has a dominant-negative effect on the suppression of spontaneous miniature release.

**Fig. 5: Syt1^PL mutation increases spontaneous transmission beyond Syt1-KO levels in autaptic- and mass- cultures.**

A previous study showed that substituting the arginine residues 398 and 399 to glutamine (R398,399Q) impaired the release clamping function of Syt1 and increased the frequency of spontaneous (mEPSC) release beyond KO levels [45]. To investigate whether the P400L mutation, located immediately next to these residues, has a similar effect on spontaneous release, we compared mEPSC rates in Syt1 null neurons expressing either GFP only or Syt1^PL (Fig. 5G). Syt1 null neurons rescued with Syt1^PL exhibited a 3.5-fold increase in mEPSC frequency compared to those that only expressed GFP (Fig. 5H), with again a small effect on mEPSC amplitude (Fig. 5H). This suggests that Syt1^PL mutant increases spontaneous release rates beyond KO levels, probably by a mechanism similar to the Syt1 R398,399Q mutant.

Increased spontaneous synaptic activity leads to shorter dendrites in Syt1^PL expressing neurons

The marked increase in spontaneous release rates caused by Syt1^PL is hard to reconcile with the reduction in total synapse number caused by this mutation. This prompted us to wonder whether the morphological effects are caused by a compensatory mechanism to normalize spontaneous release rates, or vice versa. To address this question, we analyzed the morphology of Syt1 null/Syt1 knockdown (KD) neurons rescued with either Syt1^PL or Syt1^WT in the presence and absence of tetanus neurotoxin (TeNT), which silences all synaptic vesicle release by cleaving the essential SNARE VAMP2 [46]. The difference in dendrite length and synapse number observed between Syt1^PL or Syt1^WT expressing neurons was abolished in the presence of TeNT, while synaptic density was unchanged for all conditions (Fig. 6A–D). This suggests that the morphological phenotype is driven by synaptic activity, rather than a cell-autonomous effect. Interestingly, post-hoc analysis indicated that TeNT also reduced dendrite length (Fig. 6B), but not the number of synapses (Fig. 6C) in Syt1^WT -rescued neurons, possibly due to the complete silencing of synapses, including AP-triggered neurotransmission.

**Fig. 6: Syt1^PL morphological phenotype is activity-dependent.**

To further investigate the role of spontaneous release on neuronal morphology, we tested whether receiving synaptic input from Syt1^WT neurons could rescue the morphology of Syt1^PL-expressing neurons. First, we assessed whether Syt1^PL reduced dendrite length in mass cultures by tracing sparsely labeled single neurons in the network (Fig. 6E, F). Indeed, we found a reduced dendrite length in Syt1^PL mass cultures (Fig. 6G, H), demonstrating that both the electrophysiological (Fig. 5C, D) and morphological phenotype are not restricted to autaptic cultures, but also present in mass cultures. Next, we co-cultured Syt1 null neurons rescued with either Syt1^PL or Syt1^WT at a ratio of ~1:8 with WT neurons from littermates, assuming that the rescued neurons would predominantly receive spontaneous input at normal frequencies from the surrounding WT neurons (Fig. 6I). In this preparation, the dendrite lengths of Syt1^PL-rescued neurons were similar to those of Syt1^WT-rescued neurons (Fig. 6J, K), and we found no difference in dendritic branching (Fig. 6L). These finding suggest that the observed reduction in dendrite length and dendritic branching exhibited by Syt1^PL autaptic neurons is not cell-autonomous, but might rather depend on altered synaptic input.

Discussion

Syt1^PL selectively impairs clamping of spontaneous and asynchronous release

In this study we identified a missense de novo mutation at a highly conserved location in Syt1 (P401L) in a patient with developmental delay and ASD symptoms. The PL mutant was equally well expressed and targeted to synapses as was WT Syt1. This suggests that the mutation causes disease by specific functional deficits, rather than protein instability/degradation or targeting deficits. Syt1 null neurons rescued with Syt1^PL showed a 30% reduction in dendrite length with a concomitant reduction in synapses. The amount of asynchronous release per synapse during a single AP or train stimulation was increased, and spontaneous miniature release events were drastically increased in these neurons. The overall physiological and morphological phenotype observed with Syt1^PL on Syt1 null background was also observed when this variant was expressed in WT neurons. Therefore, we conclude that this mutation causes disease due to a dominant-negative effect on Syt1 function.

While the increase in asynchronous and spontaneous release points to a presynaptic effect of Syt1^PL, synaptotagmins and SNAREs also have a postsynaptic role in membrane insertion of AMPA receptors (AMPARs) [47, 48]. One possibility is that increased spontaneous AMPAR exocytosis is responsible for the increased mEPSC amplitude in Syt1^PL-rescued neurons. An alternative explanation is the summation of simultaneous occurring mEPSC due to the high spontaneous release rates in this group. Indeed, in younger neurons with much lower mEPSC frequencies no effect on mEPSC amplitude was found, making the latter explanation more likely.

The effects on dendrite length and synapse number could arise either from a cell-autonomous postsynaptic effect of Syt1, or be induced by changes in synaptic input. The morphological differences between Syt1^PL and Syt1^WT neurons disappeared when synaptic activity was silenced by TeNT. In addition, dendrites of Syt1^PL-rescued neurons developed normally when embedded in a mass culture of wild type cells, presumably receiving normal synaptic input from neighboring neurons, but not when receiving increased spontaneous input in Syt1^PL mass culture. These findings suggest that the morphological changes are secondary to the electrophysiological phenotype. We speculate that this could be a homeostatic adaptation to the exceptionally high spontaneous miniature release rates and/or to increased AP-induced total release per synapse in these neurons [49], since no morphological defects were reported for Syt1 knockout (KO) neurons [34].

In contrast to previously described SYT1 disease variants (see below), the PL mutation did not affect the Ca²⁺-dependent fusion triggering function of Syt1. The fast component of AP-evoked EPSC’s showed normal kinetics, and normal short-term synaptic plasticity during train- or paired-pulse stimulation implied a normal vesicular release probability. Interestingly, despite the 30% reduction in synapses in Syt1^PL-rescued neurons, we found a similar total RRP for the WT and PL group, suggesting an increased primed pool per synapse in Syt1^PL-rescued neurons. Since both EPSC amplitudes and the total number of synapses were smaller in these neurons, these extra primed vesicles appear not to contribute to synchronous release, presumably docking more distantly from Ca²⁺ channels. Indeed, asynchronous release in response to a single AP or train stimulation was much more pronounced in Syt1^PL-rescued synapses. In addition, we found that asynchronous release following train stimulation decayed slower back to baseline, further suggesting that clamping of asynchronous release is impaired by this mutation. In line with this notion, the mEPSC frequency was increased 4-fold in Syt1^PL expressing neurons. Taking into account the reduced number of synapses, this translates to a 6-fold increase in spontaneous release from individual synapses. Altogether, our observations are best explained by a model in which Syt1^PL increases the RRP for asynchronous release and has a selective impairment in the clamping of spontaneous and asynchronous release, while its release triggering function remains intact. In such a scenario, vesicles in Syt1^PL and Syt1^WT-rescued synapses will respond similarly to peak Ca²⁺ during single APs, and release with the same probability when located close to Ca²⁺ channels (Fig. 6M). However, reduced clamping in Syt1^PL-rescued synapses renders vesicles more susceptible to low Ca²⁺ concentrations that occur locally immediately after the AP, or globally during train stimulation, hence increasing the probability for these vesicles to be released asynchronously.

Syt1^PL has a unique cellular phenotype compared to other Syt1 disease mutations

Previously, physiological phenotypes of other de novo mutations in SYT1-associated with neurodevelopmental disorder [7, 22] have been studied. These mutations, mostly located in the Ca²⁺-binding and membrane penetrating loops of the C2B domain (D304G, D366E, and I368T) caused an almost complete loss of AP-induced synchronous release, while the ability to clamp spontaneous release varied between the genotypes [23]. The phenotype that we found for the current Syt1^PL patient mutation, characterized by specific increases in spontaneous and asynchronous release without affecting synchronous release, is very dissimilar to those described for the C2B mutations. Spontaneous release has been proposed to play a role in guiding synapse maturation during development, synaptic scaling, homeostatic plasticity and excitability of neuronal networks [50, 51]. Furthermore, desynchronization of release could negatively impact the precise timing of neurotransmission, important for spike-timing dependent plasticity and information processing [52, 53]. As such, the mutation in the patient could potentially affect these aspects of brain function. We further show that dendritic growth was inhibited in the Syt1^PL-rescued neurons. Abnormalities in dendritic growth have been proposed to be some of the major defects in ASD [54, 55], and might be causal to suggested differences in long-range versus short-range connections in ASD [56, 57]. While several cell models for neurodevelopmental disorders display either shortened [6, 58,59,60,61,62] or elongated [58, 63, 64] dendrites, dendritic abnormalities are absent in Syt1 KO neurons [34], and have not been associated with Syt1 disease mutations reported so far [7, 22, 23]. These findings demonstrate that mutations in the same synaptic gene can cause different cellular phenotypes, but largely overlapping clinical symptoms.

Perturbation of the SNARE-Syt1 primary interface impairs clamping function of Syt1

Here we report a point mutation in Syt1 that selectively impairs its clamping function and increases priming. Decoupling of the clamping and activation roles was shown before for the experimental Syt1^9PRO mutant, but with a more drastic modification of Syt1, involving the insertion of nine prolines in the linker between the C2A and C2B domain [14, 19]. The mutated proline P401 described in the current study is at a location that forms Syt1’s primary interface with the SNARE complex [21], and is directly adjacent to two arginine residues (R399, R400 in human Syt1; R398, R399 in mouse Syt1) (Fig. 6N). These arginines protrude from the bottom of the C2B domain to interact with SNAREs at rest, most likely to prevent full zippering, thereby preventing premature neurotransmitter release [20]. Previous studies showed that mutating the positively charged arginines to neutral glutamines (Syt1^RQ) impaired the release clamping function, and increased spontaneous release rates beyond Syt1 KO levels [24, 45], similar to the effects of the PL mutation in the current study. These exceptionally high spontaneous release rates have been attributed to the C2A domain, still present in the Syt1^RQ- (and Syt1^PL-) expressing neurons, but not Syt1 KO neurons, which promotes spontaneous release in the absence of the release clamping action of the C2B domain [45]. However, contrary to what we found for the PL mutation, vesicle docking was strongly reduced, and synchronous release was completely abrogated in the RQ mutant [12, 24, 45]. We speculate that the specific loss of clamping in the PL mutant originates from rendering the primary interface less rigid through the substitution of a rigid proline with a more flexible leucine [65]. This could hamper the correct positioning of the arginines in the Syt1-SNARE interaction necessary for release clamping, while they are still available for membrane binding during docking [12] and evoked synchronous release [66].

Interestingly, the Syt1^PL synaptic phenotype shows strong similarities to some of the recently described NDD-associated mutations located in the domain of SNAP25 that forms the primary interface with Syt1 [21, 50]. In particular, the SNAP25 variants L50S and V48F, both of which are located exactly opposite to Syt1 P401 in the crystal structure [21, 29] (Fig. 6N) strongly augmented spontaneous release with mild or no impairments in evoked release [50]. Hence, mutations in different genes that are part of the same complex can produce similar cellular phenotypes, whereas different mutations in the same gene can produce different cellular phenotypes (see discussion above). This shows the importance of in vitro phenotyping to uncover disease mechanisms in patients with different mutations in presynaptic genes.

Methods and materials

Ethical statement

Consent to describe the patient was obtained from the parents and apart from sequencing, no data was collected directly from the patient. Animals were housed and bred according to institutional and Dutch governmental guidelines, and all procedures are approved by the ethical committee of the Vrije Universiteit, Amsterdam, The Netherlands.

Laboratory animals and primary neuron cultures

Syt1^−/− mice were generated by interbreeding heterozygous mice (C57BL/6 background). Hippocampal autaptic- and mass cultures were prepared as previously described [67]. In a few experiments Syt1 knockdown (KD) neurons were used, which is indicated in the text and figure legends. A detailed description of the culture methods and infection is given in the supplementary information.

Morphological analysis

Morphological parameters were obtained from confocal images of autaptic or mass cultures stained for dendritic (MAP2) and synaptic markers (Syt1 and VGLUT) and analyzed using the automated image analysis routine SynD [36]. A detailed description of the imaging and analysis methods is provided in the supplementary information.

Electrophysiology

Whole-cell voltage clamp recordings were performed in autaptic and mass cultures to measure evoked and spontaneous mEPSC release. Hypertonic sucrose application was used to estimate the readily releasable pool. All recordings were analyzed with in-house developed Matlab scripts. A detailed description of the patch-clamp experiments and analysis is provided in the supplementary information.

Statistical analysis

Statistical significance was determined using student’s- or Welch’s t tests, and Mann-Whitney U tests when normality could not be assumed. An overview of all statistical analyses and summary statistics (mean ± SD, or median ± MAD (median absolute deviation [68]) in case of deviations from normality) is provided in Table S1. All statistical tests were two-tailed, and p values below 0.05 were considered significant. A detailed description of the statistical methods is provided in the supplementary information.

References

Südhof TC. Neurotransmitter release: the last millisecond in the life of a synaptic vesicle. Neuron. 2013;80:675–90.
Article PubMed Google Scholar
Brunger AT, Choi UB, Lai Y, Leitz J, Zhou Q. Molecular mechanisms of fast neurotransmitter release. Annu Rev Biophys. 2018;47:469–97.
Article CAS PubMed PubMed Central Google Scholar
Cupertino RB, Kappel DB, Bandeira CE, Schuch JB, da Silva BS, Müller D, et al. SNARE complex in developmental psychiatry: neurotransmitter exocytosis and beyond. J Neural Transm. 2016;123:867–83.
Article CAS PubMed Google Scholar
Melland H, Carr EM, Gordon SL. Disorders of synaptic vesicle fusion machinery. J Neurochem. 2021;157:130–64.
Article CAS PubMed Google Scholar
Bonnycastle K, Davenport EC, Cousin MA. Presynaptic dysfunction in neurodevelopmental disorders: insights from the synaptic vesicle life cycle. J Neurochem. 2021;157:179–207.
Article CAS PubMed Google Scholar
Lammertse HCA, van Berkel AA, Iacomino M, Toonen RF, Striano P, Gambardella A, et al. Homozygous STXBP1 variant causes encephalopathy and gain-of-function in synaptic transmission. Brain. 2020;143:441–51.
Article PubMed Google Scholar
Baker K, Gordon SL, Melland H, Bumbak F, Scott DJ, Jiang TJ, et al. SYT1-associated neurodevelopmental disorder: a case series. Brain. 2018;141:2576–91.
Article PubMed PubMed Central Google Scholar
Melland H, Bumbak F, Kolesnik-Taylor A, Ng-Cordell E, John A, Constantinou P et al. Expanding the genotype and phenotype spectrum of SYT1-associated neurodevelopmental disorder. Genet Med. 2022; 24: 880–93
Wolfes AC, Dean C. The diversity of synaptotagmin isoforms. Curr Opin Neurobiol. 2020;63:198–209.
Article CAS PubMed Google Scholar
Südhof TC. A molecular machine for neurotransmitter release: synaptotagmin and beyond. Nat Med. 2013;19:1227–31.
Article PubMed Google Scholar
de Wit H, Walter AM, Milosevic I, Gulyás-Kovács A, Riedel D, Sørensen JB, et al. Synaptotagmin-1 docks secretory vesicles to syntaxin-1/SNAP-25 acceptor complexes. Cell. 2009;138:935–46.
Article PubMed Google Scholar
Chang S, Trimbuch T, Rosenmund C. Synaptotagmin-1 drives synchronous Ca²⁺-triggered fusion by C2B-domain-mediated synaptic-vesicle-membrane attachment. Nat Neurosci. 2018;21:33–40.
Article CAS PubMed Google Scholar
Chen Y, Hu S, Wu X, Xie Z, Wang Y, Wang B, et al. Synaptotagmin-1 is a bidirectional Ca²⁺ sensor for neuronal endocytosis. Proc Natl Acad Sci. 2022;119:e2111051119.
Article CAS PubMed PubMed Central Google Scholar
Bai H, Xue R, Bao H, Zhang L, Yethiraj A, Cui Q, et al. Different states of synaptotagmin regulate evoked versus spontaneous release. Nat Commun. 2016;7:1–9.
Article Google Scholar
Yao J, Kwon SE, Gaffaney JD, Dunning FM, Chapman ER. Uncoupling the roles of synaptotagmin I during endo-and exocytosis of synaptic vesicles. Nat Neurosci. 2012;15:243–9.
Article CAS Google Scholar
Broadie K, Bellen HJ, DiAntonio A, Littleton JT, Schwarz TL. Absence of synaptotagmin disrupts excitation-secretion coupling during synaptic transmission. Proc Natl Acad Sci. 1994;91:10727–31.
Article ADS CAS PubMed PubMed Central Google Scholar
Nishiki T-i, Augustine GJ. Dual roles of the C2B domain of synaptotagmin I in synchronizing Ca²⁺-dependent neurotransmitter release. J Neurosci. 2004;24:8542.
Article CAS PubMed PubMed Central Google Scholar
Xu J, Pang ZP, Shin O-H, Südhof TC. Synaptotagmin-1 functions as a Ca²⁺ sensor for spontaneous release. Nat Neurosci. 2009;12:759–66.
Article CAS PubMed PubMed Central Google Scholar
Huson V, van Boven MA, Stuefer A, Verhage M, Cornelisse LN. Synaptotagmin-1 enables frequency coding by suppressing asynchronous release in a temperature dependent manner. Sci Rep. 2019;9:1–19.
Google Scholar
Voleti R, Jaczynska K, Rizo J. Ca²⁺-dependent release of synaptotagmin-1 from the SNARE complex on phosphatidylinositol 4,5-bisphosphate-containing membranes. eLife. 2020;9:e57154.
Article CAS PubMed PubMed Central Google Scholar
Zhou Q, Lai Y, Bacaj T, Zhao M, Lyubimov AY, Uervirojnangkoorn M, et al. Architecture of the synaptotagmin–SNARE machinery for neuronal exocytosis. Nature. 2015;525:62–7.
Article ADS CAS PubMed PubMed Central Google Scholar
Baker K, Gordon SL, Grozeva D, van Kogelenberg M, Roberts NY, Pike M, et al. Identification of a human synaptotagmin-1 mutation that perturbs synaptic vesicle cycling. J Clin Investig. 2015;125:1670–8.
PubMed PubMed Central Google Scholar
Bradberry MM, Courtney NA, Dominguez MJ, Lofquist SM, Knox AT, Sutton RB, et al. Molecular basis for synaptotagmin-1-associated neurodevelopmental disorder. Neuron. 2020;107:52–64.e57.
Article CAS PubMed PubMed Central Google Scholar
Xue M, Ma C, Craig TK, Rosenmund C, Rizo J.The Janus-faced nature of the C 2 B domain is fundamental for synaptotagmin-1 function. Nat Struct Mol Biol. 2008;15:1160
Article CAS PubMed PubMed Central Google Scholar
Chen Y, Wang Y-H, Zheng Y, Li M, Wang B, Wang Q-W, et al. Synaptotagmin-1 interacts with PI(4,5)P2 to initiate synaptic vesicle docking in hippocampal neurons. Cell Rep. 2021;34:108842.
Article CAS PubMed Google Scholar
Niclass T, Le Guyader G, Beneteau C, Joubert M, Pizzuti A, Giuffrida MG, et al. 12q21 deletion syndrome: Narrowing the critical region down to 1.6 Mb including SYT1 and PPP1R12A. Am J Med Genet Part A. 2020;182:2133–8.
Article CAS PubMed Google Scholar
Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alföldi J, Wang Q, et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020;581:434–43.
Article ADS CAS PubMed PubMed Central Google Scholar
Chen S, Francioli LC, Goodrich JK, Collins RL, Kanai M, Wang Q, et al. A genomic mutational constraint map using variation in 76,156 human genomes. Nature 2024;625:92–100.
Article ADS CAS PubMed Google Scholar
Zhou Q, Zhou P, Wang AL, Wu D, Zhao M, Südhof TC, et al. The primed SNARE–complexin–synaptotagmin complex for neuronal exocytosis. Nature. 2017;548:420–5.
Article ADS CAS PubMed PubMed Central Google Scholar
Xue M, Ma C, Craig TK, Rosenmund C, Rizo J. The Janus-faced nature of the C2B domain is fundamental for synaptotagmin-1 function. Nat Struct Mol Biol. 2008;15:1160–8.
Article CAS PubMed PubMed Central Google Scholar
Schupp M, Malsam J, Ruiter M, Scheutzow A, Wierda KDB, Söllner TH, et al. Interactions between SNAP-25 and Synaptotagmin-1 are involved in vesicle priming, clamping spontaneous and stimulating evoked neurotransmission. J Neurosci. 2016;36:11865.
Article CAS PubMed PubMed Central Google Scholar
Bekkers JM, Stevens CF. Excitatory and inhibitory autaptic currents in isolated hippocampal neurons maintained in cell culture. Proc Natl Acad Sci. 1991;88:7834–8.
Article ADS CAS PubMed PubMed Central Google Scholar
Bekkers JM. Autaptic cultures: methods and applications. Front Synaptic Neurosci. 2020;12:18.
Article PubMed PubMed Central Google Scholar
Huson V, Meijer M, Dekker R, ter Veer M, Ruiter M, van Weering JRT, et al. Post-tetanic potentiation lowers the energy barrier for synaptic vesicle fusion independently of Synaptotagmin-1. eLife. 2020;9:e55713.
Article CAS PubMed PubMed Central Google Scholar
Rosenmund C, Stevens CF. Definition of the readily releasable pool of vesicles at hippocampal synapses. Neuron. 1996;16:1197–1207.
Article CAS PubMed Google Scholar
Schmitz SK, Hjorth JJJ, Joemai RMS, Wijntjes R, Eijgenraam S, de Bruijn P, et al. Automated analysis of neuronal morphology, synapse number and synaptic recruitment. J Neurosci Methods. 2011;195:185–93.
Article PubMed Google Scholar
Geppert M, Goda Y, Hammer RE, Li C, Rosahl TW, Stevens CF, et al. Synaptotagmin I: a major Ca²⁺ sensor for transmitter release at a central synapse. Cell. 1994;79:717–27.
Article CAS PubMed Google Scholar
Nishiki T-i, Augustine GJ. Synaptotagmin I synchronizes transmitter release in mouse hippocampal neurons. J Neurosci. 2004;24:6127–32.
Article PubMed PubMed Central Google Scholar
Neher E. Merits and limitations of vesicle pool models in view of heterogeneous populations of synaptic vesicles. Neuron. 2015;87:1131–42.
Article CAS PubMed Google Scholar
Schotten S, Meijer M, Walter AM, Huson V, Mamer L, Kalogreades L, et al. Additive effects on the energy barrier for synaptic vesicle fusion cause supralinear effects on the vesicle fusion rate. Elife. 2015;4:e05531.
Article PubMed PubMed Central Google Scholar
Chicka MC, Hui E, Liu H, Chapman ER. Synaptotagmin arrests the SNARE complex before triggering fast, efficient membrane fusion in response to Ca²⁺. Nat Struct Mol Biol. 2008;15:827–35.
Article CAS PubMed PubMed Central Google Scholar
Littleton JT, Stern M, Perin M, Bellen HJ. Calcium dependence of neurotransmitter release and rate of spontaneous vesicle fusions are altered in Drosophila synaptotagmin mutants. Proc Natl Acad Sci. 1994;91:10888–92.
Article ADS CAS PubMed PubMed Central Google Scholar
Kombian SB, Hirasawa M, Mouginot D, Chen X, Pittman QJ. Short-term potentiation of miniature excitatory synaptic currents causes excitation of supraoptic neurons. J Neurophysiol. 2000;83:2542–53.
Article CAS PubMed Google Scholar
Hirasawa M, Pittman QJ. Nifedipine facilitates neurotransmitter release independently of calcium channels. Proc Natl Acad Sci. 2003;100:6139–44.
Article ADS CAS PubMed PubMed Central Google Scholar
Courtney NA, Bao H, Briguglio JS, Chapman ER. Synaptotagmin 1 clamps synaptic vesicle fusion in mammalian neurons independent of complexin. Nat Commun. 2019;10:4076.
Article ADS PubMed PubMed Central Google Scholar
Hoogstraaten RI, van Keimpema L, Toonen RF, Verhage M. Tetanus insensitive VAMP2 differentially restores synaptic and dense core vesicle fusion in tetanus neurotoxin treated neurons. Sci Rep. 2020;10:10913.
Article ADS CAS PubMed PubMed Central Google Scholar
Wu D, Bacaj T, Morishita W, Goswami D, Arendt KL, Xu W, et al. Postsynaptic synaptotagmins mediate AMPA receptor exocytosis during LTP. Nature. 2017;544:316–21.
Article ADS CAS PubMed PubMed Central Google Scholar
Jurado S, Goswami D, Zhang Y, Molina AJM, Südhof TC, Malenka RC. LTP requires a unique postsynaptic SNARE fusion machinery. Neuron. 2013;77:542–58.
Article CAS PubMed PubMed Central Google Scholar
Okujeni S, Egert U. Self-organization of modular network architecture by activity-dependent neuronal migration and outgrowth. Elife. 2019;8:e47996.
Article CAS PubMed PubMed Central Google Scholar
Alten B, Zhou Q, Shin O-H, Esquivies L, Lin P-Y, White KI, et al. Role of aberrant spontaneous neurotransmission in SNAP25-associated encephalopathies. Neuron. 2021;109:59–72.e55.
Article CAS PubMed Google Scholar
Kavalali ET. The mechanisms and functions of spontaneous neurotransmitter release. Nat Rev Neurosci. 2015;16:5–16.
Article CAS PubMed Google Scholar
Dan Y, Poo M-m. Spike timing-dependent plasticity of neural circuits. Neuron. 2004;44:23–30.
Article CAS PubMed Google Scholar
Izhikevich EM, Desai NS, Walcott EC, Hoppensteadt FC. Bursts as a unit of neural information: selective communication via resonance. Trends Neurosci. 2003;26:161–7.
Article CAS PubMed Google Scholar
Gilbert J, Man H-Y. Fundamental elements in autism: from neurogenesis and neurite growth to synaptic plasticity. Front Cell Neurosci. 2017;11:359.
Article PubMed PubMed Central Google Scholar
Weir R, Bauman M, Jacobs B, Schumann C. Protracted dendritic growth in the typically developing human amygdala and increased spine density in young ASD brains. J Comp Neurol. 2018;526:262–74.
Article CAS PubMed Google Scholar
Just MA, Keller TA, Malave VL, Kana RK, Varma S. Autism as a neural systems disorder: a theory of frontal-posterior underconnectivity. Neurosci Biobehav Rev. 2012;36:1292–313.
Article PubMed PubMed Central Google Scholar
Belmonte MK, Allen G, Beckel-Mitchener A, Boulanger LM, Carper RA, Webb SJ. Autism and abnormal development of brain connectivity. J Neurosci. 2004;24:9228–31.
Article CAS PubMed PubMed Central Google Scholar
Deshpande A, Yadav S, Dao DQ, Wu Z-Y, Hokanson KC, Cahill MK, et al. Cellular phenotypes in human iPSC-derived neurons from a genetic model of autism spectrum disorder. Cell Rep. 2017;21:2678–87.
Article CAS PubMed PubMed Central Google Scholar
Katrancha SM, Shaw JE, Zhao AY, Myers SA, Cocco AR, Jeng AT, et al. Trio haploinsufficiency causes neurodevelopmental disease-associated deficits. Cell Rep. 2019;26:2805–17.e2809.
Article CAS PubMed PubMed Central Google Scholar
Khatri N, Gilbert JP, Huo Y, Sharaflari R, Nee M, Qiao H, et al. The autism protein Ube3A/E6AP remodels neuronal dendritic arborization via caspase-dependent microtubule destabilization. J Neurosci. 2018;38:363.
Article CAS PubMed PubMed Central Google Scholar
Moore SM, Seidman JS, Ellegood J, Gao R, Savchenko A, Troutman TD, et al. Setd5 haploinsufficiency alters neuronal network connectivity and leads to autistic-like behaviors in mice. Transl Psychiatry. 2019;9:24.
Article PubMed PubMed Central Google Scholar
Yi F, Danko T, Botelho SC, Patzke C, Pak C, Wernig M, et al. Autism-associated SHANK3 haploinsufficiency causes Ih channelopathy in human neurons. Science. 2016;352:aaf2669.
Article PubMed PubMed Central Google Scholar
Weston MC, Chen H, Swann JW. Loss of mTOR repressors Tsc1 or Pten has divergent effects on excitatory and inhibitory synaptic transmission in single hippocampal neuron cultures. Front Mol Neurosci. 2014;7:1.
Article CAS PubMed PubMed Central Google Scholar
Zaslavsky K, Zhang W-B, McCready FP, Rodrigues DC, Deneault E, Loo C, et al. SHANK2 mutations associated with autism spectrum disorder cause hyperconnectivity of human neurons. Nat Neurosci. 2019;22:556–64.
Article CAS PubMed PubMed Central Google Scholar
George RA, Heringa J. An analysis of protein domain linkers: their classification and role in protein folding. Protein Eng Des Select. 2002;15:871–9.
Article CAS Google Scholar
Voleti R, Jaczynska K, Rizo J. Ca²⁺-dependent release of synaptotagmin-1 from the SNARE complex on phosphatidylinositol 4, 5-bisphosphate-containing membranes. Elife. 2020;9:e57154.
Article CAS PubMed PubMed Central Google Scholar
Brouwer M, Farzana F, Koopmans F, Chen N, Brunner JW, Oldani S, et al. SALM 1 controls synapse development by promoting F‐actin/PIP2‐dependent Neurexin clustering. EMBO J. 2019;38:e101289.
Article PubMed PubMed Central Google Scholar
Leys C, Ley C, Klein O, Bernard P, Licata L. Detecting outliers: do not use standard deviation around the mean, use absolute deviation around the median. J Exp Soc Psychol. 2013;49:764–6.
Article Google Scholar
Lyubimov AY, Uervirojnangkoorn M, Zeldin OB, Zhou Q, Zhao M, Brewster AS, et al. Advances in X-ray free electron laser (XFEL) diffraction data processing applied to the crystal structure of the synaptotagmin-1/SNARE complex. Elife. 2016;5:e18740.
Article PubMed PubMed Central Google Scholar
Sayers EW, Bolton EE, Brister JR, Canese K, Chan J, Comeau DonaldC, et al. Database resources of the national center for biotechnology information. Nucleic Acids Res. 2021;50:D20–6.
Article PubMed Central Google Scholar
Consortium TU. UniProt: the universal protein knowledgebase in 2021. Nucleic Acids Res. 2020;49:D480–9.
Article Google Scholar

Download references

Acknowledgements

We would like to thank the patient and his parents for their cooperation. The authors thank Robbert Zalm and Ingrid Saarloos for their help with cloning and virus production, Lisa Laan and Desiree Schut for preparation of glia feeder plates, Joke Wortel and Joost Hoetjes for breeding- and genotyping of mutant mice, and Vincent Huson for developing MATLAB routines for the analysis of electrophysiological data. This work was supported by three grants (ZonMW-TOP (91216064), ZonMW-PSIDER (10250022110003), NWO-Dutch Research Agenda (NWA) (1160.18.200)) from the Netherlands Organization for Scientific Research (NWO) to MV and LNC.

Author information

Authors and Affiliations

Department of Functional Genomics, Center for Neurogenomics and Cognitive Research (CNCR), Vrije Universiteit (VU) Amsterdam, 1081 HV, Amsterdam, The Netherlands
Maaike A. van Boven, Marta Mestroni & Matthijs Verhage
Department of Human Genetics, Amsterdam UMC, 1105 AZ, Amsterdam, The Netherlands
Petra J. G. Zwijnenburg
Department of Functional Genomics and Department of Human Genetics, Center for Neurogenomics and Cognitive Research (CNCR), Amsterdam UMC-Location VUmc, 1081 HV, Amsterdam, The Netherlands
Matthijs Verhage & L. Niels Cornelisse

Authors

Maaike A. van Boven
View author publications
You can also search for this author in PubMed Google Scholar
Marta Mestroni
View author publications
You can also search for this author in PubMed Google Scholar
Petra J. G. Zwijnenburg
View author publications
You can also search for this author in PubMed Google Scholar
Matthijs Verhage
View author publications
You can also search for this author in PubMed Google Scholar
L. Niels Cornelisse
View author publications
You can also search for this author in PubMed Google Scholar

Contributions

LC and MvB designed the study. MvB and MM performed experiments and analyzed data. PZ contributed patient evaluation and supervised the collection of clinical data. MvB and LC prepared the manuscript with input from PZ. MV reviewed and edited the manuscript. LC and MV supervised the project.

Corresponding author

Correspondence to L. Niels Cornelisse.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Table S1

Supplementary material

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Cite this article

van Boven, M.A., Mestroni, M., Zwijnenburg, P.J.G. et al. A de novo missense mutation in synaptotagmin-1 associated with neurodevelopmental disorder desynchronizes neurotransmitter release. Mol Psychiatry (2024). https://doi.org/10.1038/s41380-024-02444-5

Download citation

Received: 10 November 2022
Revised: 12 January 2024
Accepted: 22 January 2024
Published: 06 February 2024
DOI: https://doi.org/10.1038/s41380-024-02444-5